Microcarriers Market - By Products (Consumables {Media, Microcarrier Beads}, Equipment {Bioreactor, Cell Counter}), Application (Biopharmaceutical Production, Regenerative Medicine), End-user (CROs, Research Institutes), Global Forecast, 2024 – 2032

Microcarriers Market Size

Microcarriers Market size was valued at USD 1.8 billion in 2023 and is anticipated to register a CAGR of over 9.5% between 2024 and 2032. The high market growth can be attributed to factors such as increasing cases of cancer and chronic diseases along with the advancements in cell culture technologies.
 

Also, rising investments in biotechnology & life sciences research activities, increasing focus on regenerative medicine, global need for vaccine production, and expanding stem cell therapy based research are few of the other factors driving the market growth. For instance, according to the WCRF International, there were an estimated 18.1 million cancer cases around the world in 2020.
 

The cancer research involving the cultivation and study of cancer cells in vitro to understand their behaviour, response to treatments, and molecular characteristics is expected to be on surge. Thus, microcarriers provide a platform for the efficient growth and expansion of cancer cells, supporting research efforts aimed at advancing to understand the disease, thereby driving the growth of the market.
 

Microcarriers are small, typically spherical particles or beads designed for use in cell culture and bioprocessing applications. These particles provide a surface for the attachment and growth of anchorage-dependent cells, allowing for the expansion of cell populations in a controlled environment. They are commonly used in bioreactors and other cell culture systems to support the production of cells for various purposes, including the manufacturing of biopharmaceuticals, vaccines, and cell-based therapies.
 

Microcarrier Market Trends

• Advancements in cell culture technologies play a significant role as driver for the market. For instance, Cytiva has developed the macroporous microcarriers, such as Cytopore 2 microcarriers, that has enabled the growth of cells in 3D and encouraged cell growth into the bead, while the micropores provide maximum nutrient availability. Therefore, as they often aim to improve scalability, the microcarriers are crucial in large-scale bioprocessing and biomanufacturing, thereby providing a platform for efficient cell growth in bioreactors.
   
• Similarly, progress in stem cell research and therapeutic applications requires sophisticated cell culture techniques. Hence, microcarriers play a key role in the expansion and differentiation of stem cells, contributing to advancements in regenerative medicine, thereby fostering the market progress.
   

However, the concerns relate to the interaction between microcarriers, and the cells cultured on them, as well as the potential immune response when microcarriers are introduced into living organisms. Thus, biocompatibility and immunogenicity concerns represent potential pitfalls for the market.
 

Microcarriers Market Analysis

Based on product, the market is bifurcated into consumables and equipment. The consumables segment held the largest business share of 67.5% in 2023.
 

• Consumables align with the ongoing single-use trend, as they are designed for one-time use, thereby eliminating the need for complex cleaning and sterilization processes associated with reusable equipment. This trend has driven the adoption of consumables in the market.
   
• Additionally, consumables provide flexibility in scale-up scenarios. For instance, Sartorius AG offers microcarrier beads that are animal component free as well as animal protein coated for adherent cell culture. These microcarrier beads can be extensively used during various procedures and thus increases the utilization of consumables. Therefore, bioprocess engineers can easily scale cell culture operations by adding more units of pre-sterilized microcarriers as needed.

Based on application, the microcarrier market is classified into biopharmaceutical production, regenerative medicine, and other applications. The biopharmaceutical production is expected to exhibit 9.6% CAGR between 2024 and 2032.
 

• Biopharmaceuticals, including vaccine and therapeutic production, often require the large-scale cultivation of cells. As, microcarriers provide a platform for efficient and scalable cell culture, supporting the growth of cells needed to produce biopharmaceuticals.
   
• Also, various approval of biosimilars has led to the surge in the biopharmaceutical production processes and research pertaining to innovation. The microcarriers are scalable, and their use facilitates the upscaling of bioprocesses. Consequently, biopharmaceutical production often requires the transition from laboratory-scale experiments to larger production scales, and microcarriers support this scalability, thus escalating the segment expansion.
   

Based on end-user, the microcarrier market is divided into pharmaceutical & biotechnology companies, CROs & CMOs, academic & research institutes, and cell banks. The pharmaceutical & biotechnology companies’ segment is expected to reach the largest market revenue of USD 1.6 billion by 2032.
 

• The substantial demand for bioprocessing technologies, driven by the need for large quantities of biopharmaceuticals, has led pharmaceutical and biotechnology companies to be major consumers of microcarriers.
   
• Also, the development of cell-based therapies, including CAR-T cell therapies and other advanced cell therapies, is a growing area in biotechnology. Hence, usage of microcarriers may support the expansion and production of therapeutic cells needed for these innovative treatments.
   
• Additionally, the ongoing need for vaccines, including those for emerging infectious diseases, further propels the demand for microcarriers, with pharmaceutical companies driving advancements in vaccine manufacturing, thereby boosting the segment landscape.

In 2023, North America held a significant share of 40.7% in the microcarriers market.
 

• The region is home to a significant number of leading biopharmaceutical and biotechnology companies involved in research, development, and production of innovative therapeutics. These companies extensively use microcarriers in their bioprocessing and cell culture applications. Also, increasing adoption of biologics and biosimilars contribute to the demand for microcarriers.
   

Microcarriers Market Share

The microcarriers industry is characterized by diverse players competing in the industry. Thermo Fisher Scientific Inc., Sartorious AG, Merck KGaA, and Corning Incorporated account for significant market share. These prominent players adopt a combination of strategic initiatives to provide comprehensive range of products, such as collaboration & partnership, global expansion, research and development, market access and commercialization, product diversification, and regulatory compliance to maintain a competitive edge in the market.
 

Microcarriers Market Companies

Foremost players operating in the microcarriers industry are as mentioned below:

• Bio-Rad Laboratories, Inc.
• Corning Incorporated
• Cytiva
• denovoMATRIX GmbH
• Eppendorf AG
• Fujiform Holdings Corporation
• Lonza Group Ltd.
• Merck KGaA
• Sartorious AG
• Thermo Fisher Scientific Inc.
   

Microcarrier Industry News:

• In August 2022, Thermo Fisher Scientific Inc, completed the planned expansion of its U.S. dry powder media manufacturing capacity in Grand Island, New York. The facility aimed to increase the demand for cell culture media used in the manufacturing of new vaccines and biologics. This strategy enhanced the company to expand its business portfolio.
   
• In May 2022, denovoMATRIX GmbH launched its beadMATRIX, a ready-to use microcarrier with MSC-optimized coating for a new level of performance. This is ideally suited for use in shaker flasks, shaker bags, stirred tank or vertical wheel bioreactors. This strategy helped company to increase the product portfolio and sales.
   

The microcarriers market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Consumables
  • Microcarrier beads
    • Collagen coated beads
    • Cationic beads
    • Protein coated beads
    • Untreated beads
    • Other microcarrier beads
  • Media
    • Serum based media
    • Serum-free media
    • Other media
  • Reagents
  • Other consumables
• Equipment
  • Bioreactor
    • Single-use bioreactor
    • Stainless steel bioreactor
  • Culture vessel
  • Cell counter
  • Filtration system
  • Other equipment

Market, By Application

• Biopharmaceutical production       
  • Vaccine production
  • Therapeutics production
• Regenerative medicine       
• Other applications   

Market, By End-user

• Pharmaceutical & biotechnology companies
• CROs & CMOs
• Academic & research institutes
• Cell banks

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East and Africa